Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...

A study reveals potentially fatal side effects of GLP-1 drugs, that people are using to lose weight. It’s well known that ...

A WOMAN who’s shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker ...

SHOPPING: Take charge of your health with help from Hims, the weight loss program that puts your specific needs front and ...

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...

Polycystic Ovary Syndrome or PCOS affects millions of women in the United States. There is currently no standard treatment for it. Weight loss drugs like semaglutide are now showing positive results.

First Kellogg, then Kraft Heinz. Call it the anti-gestalt effect: the whole of a company can be worth less than its sum of ...

On Thursday’s episode of Mad Money, host Jim Cramer turned his focus to large-cap stocks that surged by $10 or more in a single day.

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.